Subscribe

Risk Factors of Park et al for Severe Hyperbilirubinemia in an HIV-Positive Patient Receiving Atazanavir

Specialty:

Clinical Pharmacology & Toxicology
Emergency Medicine & Critical Care
Emergency Medicine & Critical Care
Nephrology, Urology, Obstetrics & Gynecology, Pedatrics, Genetics

Objective:

ICD-10:

Description:

Park et al identified risk factors for severe hyperbilirubinemia in an HIV-patient receiving atazanavir therapy. These can help to identify a patient who should avoid this medication. The authors are from Seoul National University.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone